Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.5384343879980685e-50,299.67982924226254,34222.749375990155,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",9.519128954992757e-48,0,0,75
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.1375654675097743e-37,113.78092243186583,9563.536992975061,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",5.882935251580827e-35,0,0,58
3,Oxidative phosphorylation WP623,3.6182725208760966e-21,65.06237218813907,3062.374618186917,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",4.522840651095121e-19,0,0,34
4,Nonalcoholic fatty liver disease WP4396,9.231181530203797e-20,10.919209177446913,478.57927267038764,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'BAX']",8.65423268456606e-18,0,0,48
5,Mitochondrial complex I assembly model OXPHOS system WP4324,5.583202178141675e-17,98.7261663286004,3694.746224371527,"['NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3']",4.187401633606256e-15,0,0,26
6,Mitochondrial CIV Assembly WP4922,1.0754933113391711e-11,67.79879275653923,1712.3030258787908,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",6.72183319586982e-10,0,0,18
7,Mitochondrial complex III assembly WP4921,2.999905001156961e-05,29.83266932270916,310.6877059164019,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0016070919649055148,0,0,8
8,Eukaryotic Transcription Initiation WP405,0.00012188559277382519,14.912350597609562,134.39648185682486,"['GTF2A2', 'TAF13', 'POLR2E', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.004975470325526283,0,0,8
9,Pyrimidine metabolism WP4022,0.00012192922081756239,5.40184629073518,48.68181603067858,"['NME2', 'NME1', 'POLE4', 'POLE3', 'POLR2E', 'POLR3H', 'POLR2I', 'POLE', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.004975470325526283,0,0,13
10,mRNA Processing WP411,0.0001326792086807009,6.847985347985348,61.1359117503567,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'NCBP2', 'SRSF3', 'SNRPE', 'SNU13', 'HNRNPA1', 'SRSF9', 'LSM2']",0.004975470325526283,0,0,11
11,Cellular Proteostasis WP4918,0.00043235432098889895,inf,inf,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.014739351851894284,0,0,5
12,7q11.23 copy number variation syndrome WP4932,0.0016432635872419884,3.2694138276553106,20.96044425050854,"['ATP5PB', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'UBE2L6', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'EIF4H', 'ATP5PO', 'GAPDH', 'VAMP2']",0.051351987101312134,0,0,14
13,Ciliary landscape WP4352,0.0021070184328754456,2.8487282463186077,17.55523481962822,"['NUDC', 'NDUFA5', 'SSNA1', 'H3F3A', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'PSMD7', 'EXOSC4', 'RAB14', 'NEFL', 'CALM2']",0.06077937787140709,0,0,16
14,Synaptic Vesicle Pathway WP2267,0.0025306717456468073,4.142825460190729,24.771074058163375,"['RAB3A', 'SLC32A1', 'AP2S1', 'SLC17A6', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'VAMP2', 'CPLX3']",0.06778585032982519,0,0,10
15,Computational Model of Aerobic Glycolysis WP4629,0.004232924137522968,7.439363817097416,40.65509840836077,"['LDHA', 'TPI1', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.09920915947319456,0,0,6
16,Cori Cycle WP1946,0.004232924137522968,7.439363817097416,40.65509840836077,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.09920915947319456,0,0,6
17,Cholesterol Biosynthesis Pathway WP197,0.008464076993934162,14.857142857142858,70.89716113659375,"['IDI1', 'HMGCS1', 'PMVK', 'MSMO1']",0.1714809866362327,0,0,4
18,Base Excision Repair WP4752,0.008688369989569124,5.578031809145129,26.47205563077255,"['POLE4', 'NEIL2', 'TDG', 'APEX1', 'POLE3', 'POLE']",0.1714809866362327,0,0,6
19,Photodynamic therapy-induced unfolded protein response WP3613,0.008688369989569124,5.578031809145129,26.47205563077255,"['NARS', 'XBP1', 'DDIT3', 'DNAJB9', 'CALR', 'HSP90B1']",0.1714809866362327,0,0,6
20,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.009605568076544837,inf,inf,"['COX8A', 'GSTP1', 'COX5A']",0.17826812687825433,0,0,3
21,Proteasome Degradation WP183,0.009983015105182243,3.351445663010967,15.439674882182175,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMC3', 'H2AFZ', 'PSME1', 'PSMB10', 'PSMA7']",0.17826812687825433,0,0,9
22,Non-small cell lung cancer WP4255,0.015710851479597686,4.461232604373757,18.529299685858085,"['BAD', 'GADD45A', 'CRABP1', 'CYCS', 'BAX', 'HRAS']",0.26779860476586964,0,0,6
23,Fatty acid transporters WP5061,0.021120183393980765,7.426587301587301,28.648254622763258,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.34435081620620817,0,0,4
24,Alzheimer's disease WP2059,0.023115303752286615,2.9760956175298805,11.211727109130084,"['PSENEN', 'ATP5MD', 'CDK5', 'BAD', 'CYCS', 'CALM3', 'GAPDH', 'CALM2']",0.34512070320334887,0,0,8
25,DNA Repair Pathways Full Network WP4946,0.023115303752286615,2.9760956175298805,11.211727109130084,"['POLE4', 'NEIL2', 'CENPX', 'TDG', 'APEX1', 'POLE3', 'RAD23A', 'POLE']",0.34512070320334887,0,0,8
26,VEGFA-VEGFR2 Signaling Pathway WP3888,0.024338046351398055,1.5642156165552552,5.812178584339291,"['SET', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'PGK1', 'RPLP2', 'DNAJB9', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'HRAS', 'SLC25A25', 'SDF2L1', 'SSR4', 'RPS6', 'RPL13A', 'CYCS', 'RPL27', 'RPL26', 'CALR', 'ALDOA', 'GAPDH', 'SLC25A11', 'PTMA', 'ARF6']",0.34512070320334887,0,0,33
27,Melanoma WP4685,0.02484869063064112,3.2536069651741295,12.021915767688828,"['BAD', 'GADD45A', 'KIT', 'BAX', 'CALM3', 'HRAS', 'CALM2']",0.34512070320334887,0,0,7
28,HIF1A and PPARG regulation of glycolysis WP2456,0.03230626663674363,11.13181367690783,38.20988425678128,"['LDHA', 'TPI1', 'GAPDH']",0.4038283329592954,0,0,3
29,Methionine De Novo and Salvage Pathway WP3580,0.03230626663674363,11.13181367690783,38.20988425678128,"['AHCY', 'ODC1', 'TXN']",0.4038283329592954,0,0,3
30,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.03230626663674363,11.13181367690783,38.20988425678128,"['IDI1', 'HMGCS1', 'PMVK']",0.4038283329592954,0,0,3
31,Translation Factors WP107,0.03625537145055699,2.891321171918187,9.590997290612341,"['EEF1B2', 'EEF1G', 'EIF5', 'EIF6', 'EIF3I', 'EIF4H', 'EIF1']",0.4385730417406088,0,0,7
32,Ferroptosis WP4313,0.03956144134452793,3.1848906560636183,10.28687940810485,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.458336273298867,0,0,6
33,Parkinson's disease pathway WP2371,0.04179244016906247,3.7140019860973186,11.792104171448004,"['PINK1', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.458336273298867,0,0,5
34,Glycolysis and Gluconeogenesis WP534,0.04432045300206045,2.1885640483738404,6.820241874792766,"['LDHA', 'TPI1', 'GOT1', 'MDH2', 'MPC2', 'PGAM1', 'PGK1', 'ALDOA', 'PFKM', 'GAPDH']",0.458336273298867,0,0,10
35,Cytosine methylation WP3585,0.04522251229882154,inf,inf,"['TDG', 'TET3']",0.458336273298867,0,0,2
36,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.04522251229882154,inf,inf,"['ELOB', 'ELOC']",0.458336273298867,0,0,2
37,Mevalonate pathway WP3963,0.04522251229882154,inf,inf,"['HMGCS1', 'PMVK']",0.458336273298867,0,0,2
38,Androgen receptor signaling pathway WP138,0.05903251252000607,2.2874655225252836,6.472765536183858,"['SUMO1', 'PRDX1', 'BAG1', 'DSTN', 'STUB1', 'PARK7', 'CALR', 'RAN']",0.5712880092194212,0,0,8
39,Ras signaling WP4223,0.06023399392839097,1.9487179487179487,5.474958938877553,"['GNG10', 'GNG3', 'SHC3', 'RASA4B', 'BAD', 'KIT', 'RAC3', 'CALM3', 'CALM2', 'HRAS', 'ARF6']",0.5712880092194212,0,0,11
40,NO/cGMP/PKG mediated Neuroprotection WP4008,0.06352712094966231,3.094174114531612,8.528436104038434,"['BAD', 'NPPA', 'NEFL', 'CYCS', 'CALM2']",0.5712880092194212,0,0,5
41,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.06806960600660426,5.564420218037661,14.952846224698948,"['MAP1LC3A', 'ATG101', 'FTL']",0.5712880092194212,0,0,3
42,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.06806960600660426,5.564420218037661,14.952846224698948,"['EIF5', 'EIF3I', 'EIF1']",0.5712880092194212,0,0,3
43,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.06855456110633054,3.7113095238095237,9.94677469288949,"['IDI1', 'HMGCS1', 'PMVK', 'MSMO1']",0.5712880092194212,0,0,4
44,Kit receptor signaling pathway WP304,0.06855456110633054,3.7113095238095237,9.94677469288949,"['BAD', 'RPS6', 'KIT', 'HRAS']",0.5712880092194212,0,0,4
45,Nucleotide Excision Repair WP4753,0.06855456110633054,3.7113095238095237,9.94677469288949,"['POLE4', 'POLE3', 'RAD23A', 'POLE']",0.5712880092194212,0,0,4
46,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.09043478127939628,2.651439920556107,6.3717451038359485,"['SHC3', 'BAD', 'RPS6', 'BAX', 'HRAS']",0.7215541059526299,0,0,5
47,PPAR signaling pathway WP3942,0.09043478127939628,2.651439920556107,6.3717451038359485,"['FABP3', 'FABP5', 'FABP6', 'DBI', 'CPT1B']",0.7215541059526299,0,0,5
48,GABA receptor Signaling WP4159,0.10320592205945259,2.9682539682539684,6.740990969747951,"['SLC32A1', 'AP2S1', 'GAD2', 'AP2M1']",0.7898412402509126,0,0,4
49,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.10320592205945259,2.9682539682539684,6.740990969747951,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.7898412402509126,0,0,4
50,DNA Mismatch Repair WP531,0.11501906631122699,3.7086223984142714,8.020479563777668,"['POLE4', 'POLE3', 'POLE']",0.7940213833059528,0,0,3
51,Glycosylation and related congenital defects WP4521,0.11501906631122699,3.7086223984142714,8.020479563777668,"['DPM2', 'DPM3', 'MPI']",0.7940213833059528,0,0,3
52,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.11645646955153975,7.413861386138614,15.941564460560022,"['MDH2', 'IDH3B']",0.7940213833059528,0,0,2
53,Fatty acid beta-oxidation WP143,0.11645646955153975,7.413861386138614,15.941564460560022,"['TPI1', 'CPT1B']",0.7940213833059528,0,0,2
54,Hedgehog Signaling Pathway Netpath WP47,0.11645646955153975,7.413861386138614,15.941564460560022,"['SMO', 'SAP18']",0.7940213833059528,0,0,2
55,Peroxiredoxin 2 induced ovarian failure WP4873,0.11645646955153975,7.413861386138614,15.941564460560022,"['STAR', 'BAX']",0.7940213833059528,0,0,2
56,EGF/EGFR signaling pathway WP437,0.14306925830163958,1.7473634872275603,3.3976197686676577,"['NDUFA13', 'STMN1', 'AP2S1', 'NEDD8', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.9050409994543034,0,0,8
57,Amyotrophic lateral sclerosis (ALS) WP2447,0.14414826150564222,2.4728835978835977,4.789760178737448,"['BAD', 'NEFL', 'BAX', 'SOD1']",0.9050409994543034,0,0,4
58,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.14414826150564222,2.4728835978835977,4.789760178737448,"['ACLY', 'IDI1', 'HMGCS1', 'DBI']",0.9050409994543034,0,0,4
59,Imatinib and Chronic Myeloid Leukemia WP3640,0.14414826150564222,2.4728835978835977,4.789760178737448,"['SPRED2', 'GADD45A', 'KIT', 'PIM2']",0.9050409994543034,0,0,4
60,Cell cycle WP179,0.14480655991268854,1.67123629112662,3.229424304833524,"['CDKN2D', 'ANAPC13', 'PTTG1', 'YWHAQ', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.9050409994543034,0,0,9
61,Copper homeostasis WP3286,0.15840908022704056,2.061127661922101,3.797781222828917,"['SCO2', 'COX17', 'MT3', 'ATOX1', 'SOD1']",0.9276404577411196,0,0,5
62,Metabolic reprogramming in colon cancer WP4290,0.1656622743161495,1.8553677932405566,3.335587742366238,"['ACLY', 'LDHA', 'MDH2', 'PGAM1', 'PGK1', 'GAPDH']",0.9276404577411196,0,0,6
63,Glycolysis in senescence WP5049,0.1704868521001333,2.7807234886025767,4.919369856847451,"['LDHA', 'PGK1', 'GAPDH']",0.9276404577411196,0,0,3
64,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.1704868521001333,2.7807234886025767,4.919369856847451,"['STAR', 'FSHR', 'HRAS']",0.9276404577411196,0,0,3
65,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.19021749491270884,2.119047619047619,3.516744201851979,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'DDIT3']",0.9276404577411196,0,0,4
66,IL-3 signaling pathway WP286,0.19021749491270884,2.119047619047619,3.516744201851979,"['YWHAQ', 'YWHAB', 'BAD', 'HRAS']",0.9276404577411196,0,0,4
67,Cytosolic DNA-sensing pathway WP4655,0.19830530400833218,1.8545183714001987,3.000513356071064,"['POLR2E', 'POLR3H', 'POLR3K', 'POLR2K', 'POLR2L']",0.9276404577411196,0,0,5
68,Serotonin and anxiety WP3947,0.2006066971626344,3.705940594059406,5.9532563917863515,"['POMC', 'CRH']",0.9276404577411196,0,0,2
69,Alanine and aspartate metabolism WP106,0.2006066971626344,3.705940594059406,5.9532563917863515,"['GOT1', 'GAD2']",0.9276404577411196,0,0,2
70,Autophagy WP4923,0.2006066971626344,3.705940594059406,5.9532563917863515,"['MAP1LC3B', 'ATG101']",0.9276404577411196,0,0,2
71,Trans-sulfuration pathway WP2333,0.2006066971626344,3.705940594059406,5.9532563917863515,"['AHCY', 'GOT1']",0.9276404577411196,0,0,2
72,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.2006066971626344,3.705940594059406,5.9532563917863515,"['CD80', 'VIP']",0.9276404577411196,0,0,2
73,Cysteine and methionine catabolism WP4504,0.2006066971626344,3.705940594059406,5.9532563917863515,"['AHCY', 'GOT1']",0.9276404577411196,0,0,2
74,Dual hijack model of Vif in HIV infection WP3300,0.2006066971626344,3.705940594059406,5.9532563917863515,"['ELOB', 'ELOC']",0.9276404577411196,0,0,2
75,Gastric acid production WP2596,0.2006066971626344,3.705940594059406,5.9532563917863515,"['CCK', 'VIP']",0.9276404577411196,0,0,2
76,Lipid Metabolism Pathway WP3965,0.2006066971626344,3.705940594059406,5.9532563917863515,"['ACLY', 'PRKAR1A']",0.9276404577411196,0,0,2
77,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.2006066971626344,3.705940594059406,5.9532563917863515,"['BAD', 'HRAS']",0.9276404577411196,0,0,2
78,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.2006066971626344,3.705940594059406,5.9532563917863515,"['PTTG1', 'ANAPC11']",0.9276404577411196,0,0,2
79,The alternative pathway of fetal androgen synthesis WP4524,0.2127388783086301,inf,inf,['STAR'],0.9276404577411196,0,0,1
80,"Cerebral organic acidurias, including diseases WP4519",0.2127388783086301,inf,inf,['MDH2'],0.9276404577411196,0,0,1
81,Energy Metabolism WP1541,0.2127388783086301,inf,inf,['MEF2D'],0.9276404577411196,0,0,1
82,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.2127388783086301,inf,inf,['MAP1LC3A'],0.9276404577411196,0,0,1
83,miRNA Biogenesis WP2338,0.2127388783086301,inf,inf,['RAN'],0.9276404577411196,0,0,1
84,Mitochondrial CII Assembly WP4920,0.2127388783086301,inf,inf,['SDHAF1'],0.9276404577411196,0,0,1
85,Nanoparticle triggered autophagic cell death WP2509,0.2127388783086301,inf,inf,['MAP1LC3A'],0.9276404577411196,0,0,1
86,Nanoparticle-mediated activation of receptor signaling WP2643,0.2127388783086301,inf,inf,['HRAS'],0.9276404577411196,0,0,1
87,Selenium Micronutrient Network WP15,0.2155730477987371,1.4081091322470634,2.160680743396247,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'TXN', 'SELENOK', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.9291941715462807,0,0,11
88,IL-18 signaling pathway WP4754,0.2308043417873847,1.260448136958711,1.8480500667595614,"['NRN1', 'IMP3', 'BAD', 'COX17', 'TNFRSF11B', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'ARL4D', 'NACA', 'TMSB4X', 'STMN1', 'NPPA', 'CYCS', 'BAX', 'RPS11', 'ITM2C', 'ARF6']",0.9545861269855257,0,0,19
89,TP53 network WP1742,0.23164623348182092,2.22398414271556,3.2526745011686975,"['SUMO1', 'GADD45A', 'BAX']",0.9545861269855257,0,0,3
90,IL-6 signaling pathway WP364,0.23164623348182092,2.22398414271556,3.2526745011686975,"['BAD', 'VIP', 'NR2F6']",0.9545861269855257,0,0,3
91,Nanomaterial induced apoptosis WP2507,0.23164623348182092,2.22398414271556,3.2526745011686975,"['ENDOG', 'BAX', 'CYCS']",0.9545861269855257,0,0,3
92,Endometrial cancer WP4155,0.24010885432282095,1.8536706349206349,2.6445631214155947,"['BAD', 'GADD45A', 'BAX', 'HRAS']",0.9620591484258388,0,0,4
93,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.24115615987207692,1.6854744064277332,2.397268095846405,"['BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.9620591484258388,0,0,5
94,Modulators of TCR signaling and T cell activation WP5072,0.24115615987207692,1.6854744064277332,2.397268095846405,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7', 'MEF2D']",0.9620591484258388,0,0,5
95,Senescence and Autophagy in Cancer WP615,0.256089865880706,1.3912013958125624,1.8951319055752898,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'MAP1LC3A', 'HMGA1', 'ING1', 'HRAS', 'GABARAP', 'SLC39A3']",0.9834184288734489,0,0,9
96,Acute viral myocarditis WP4298,0.2788090819903062,1.4831013916500995,1.894258661833725,"['ENDOG', 'CD80', 'RAC3', 'CYCS', 'BAX', 'AIF1']",0.9834184288734489,0,0,6
97,G Protein Signaling Pathways WP35,0.2861551378750828,1.5446044356173452,1.932641777008742,"['GNG10', 'GNG3', 'PRKAR1A', 'HRAS', 'CALM2']",0.9834184288734489,0,0,5
98,BDNF-TrkB Signaling WP3676,0.28896475305554187,2.46996699669967,3.066341911365659,"['HOMER1', 'HRAS']",0.9834184288734489,0,0,2
99,Tumor suppressor activity of SMARCB1 WP4204,0.28896475305554187,2.46996699669967,3.066341911365659,"['SMO', 'H3F3A']",0.9834184288734489,0,0,2
100,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.28896475305554187,2.46996699669967,3.066341911365659,"['FSHR', 'RPS6']",0.9834184288734489,0,0,2
101,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.28896475305554187,2.46996699669967,3.066341911365659,"['BAD', 'BAX']",0.9834184288734489,0,0,2
102,Nucleotide metabolism WP404,0.28896475305554187,2.46996699669967,3.066341911365659,"['NME2', 'OAZ1']",0.9834184288734489,0,0,2
103,Osteoclast Signaling WP12,0.28896475305554187,2.46996699669967,3.066341911365659,"['ATP6V1G1', 'TNFRSF11B']",0.9834184288734489,0,0,2
104,RalA downstream regulated genes WP2290,0.28896475305554187,2.46996699669967,3.066341911365659,"['RAC3', 'HRAS']",0.9834184288734489,0,0,2
105,Genotoxicity pathway WP4286,0.2924991697167683,1.6472663139329806,2.024973691588545,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9834184288734489,0,0,4
106,MET in type 1 papillary renal cell carcinoma WP4205,0.29586638395642534,1.8528245787908821,2.256457470175827,"['BAD', 'RPL11', 'HRAS']",0.9834184288734489,0,0,3
107,p38 MAPK Signaling Pathway WP400,0.29586638395642534,1.8528245787908821,2.256457470175827,"['DDIT3', 'HRAS', 'MEF2D']",0.9834184288734489,0,0,3
108,Pathways in clear cell renal cell carcinoma WP4018,0.3083503628927901,1.3659073055773763,1.607015351788283,"['ACLY', 'LDHA', 'TPI1', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.9834184288734489,0,0,7
109,Small cell lung cancer WP4658,0.33249853901344534,1.4254067680085556,1.56954363361103,"['GADD45A', 'CYCS', 'BAX', 'CKS1B', 'SKP1']",0.9834184288734489,0,0,5
110,Amino Acid metabolism WP3925,0.33249853901344534,1.4254067680085556,1.56954363361103,"['ACLY', 'LDHA', 'GOT1', 'MDH2', 'ODC1']",0.9834184288734489,0,0,5
111,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.33249853901344534,1.4254067680085556,1.56954363361103,"['POMC', 'BAD', 'NPPA', 'RPS6', 'HRAS']",0.9834184288734489,0,0,5
112,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3461351948373713,1.4821428571428572,1.5724436612246775,"['APEX1', 'RPS6', 'HRAS', 'MYL12B']",0.9834184288734489,0,0,4
113,Pancreatic adenocarcinoma pathway WP4263,0.3461351948373713,1.4821428571428572,1.5724436612246775,"['BAD', 'GADD45A', 'RAC3', 'BAX']",0.9834184288734489,0,0,4
114,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.3461351948373713,1.4821428571428572,1.5724436612246775,"['BAD', 'STMN1', 'BAX', 'HRAS']",0.9834184288734489,0,0,4
115,Aryl Hydrocarbon Receptor Netpath WP2586,0.36088842143071453,1.5877106045589693,1.618173135218569,"['CDC37', 'AIP', 'HRAS']",0.9834184288734489,0,0,3
116,ErbB signaling pathway WP673,0.36088842143071453,1.5877106045589693,1.618173135218569,"['SHC3', 'BAD', 'HRAS']",0.9834184288734489,0,0,3
117,Integrin-mediated Cell Adhesion WP185,0.36088842143071453,1.5877106045589693,1.618173135218569,"['SHC3', 'RAC3', 'HRAS']",0.9834184288734489,0,0,3
118,Notch Signaling Pathway Netpath WP61,0.36088842143071453,1.5877106045589693,1.618173135218569,"['PSENEN', 'SKP1', 'DLL3']",0.9834184288734489,0,0,3
119,One-carbon metabolism and related pathways WP3940,0.36088842143071453,1.5877106045589693,1.618173135218569,"['GPX4', 'GAD2', 'SOD1']",0.9834184288734489,0,0,3
120,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.36088842143071453,1.5877106045589693,1.618173135218569,"['STAR', 'CALM3', 'CALM2']",0.9834184288734489,0,0,3
121,Integrated breast cancer pathway WP1984,0.36187731078629193,1.3079172026663548,1.3294324996147189,"['GADD45A', 'BAD', 'ODC1', 'BAX', 'PHB', 'FAU']",0.9834184288734489,0,0,6
122,Myometrial relaxation and contraction pathways WP289,0.3710147139713929,1.1706315789473685,1.1606970806157972,"['RGS4', 'GNG3', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'GSTO1', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'ACTG1', 'YWHAH']",0.9834184288734489,0,0,12
123,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.37593757248266985,1.851980198019802,1.8118518244604545,"['HOMER1', 'HRAS']",0.9834184288734489,0,0,2
124,Type 2 papillary renal cell carcinoma WP4241,0.37593757248266985,1.851980198019802,1.8118518244604545,"['ELOB', 'ELOC']",0.9834184288734489,0,0,2
125,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.37593757248266985,1.851980198019802,1.8118518244604545,"['LDHA', 'RPS6']",0.9834184288734489,0,0,2
126,Histone Modifications WP2369,0.37593757248266985,1.851980198019802,1.8118518244604545,"['SET', 'H3F3A']",0.9834184288734489,0,0,2
127,16p11.2 proximal deletion syndrome WP4949,0.37942170627336785,1.3232373386295928,1.2823585820972727,"['TMEM219', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9834184288734489,0,0,5
128,Regulation of Actin Cytoskeleton WP51,0.37942170627336785,1.3232373386295928,1.2823585820972727,"['TMSB4X', 'BRK1', 'RAC3', 'CD14', 'ACTG1']",0.9834184288734489,0,0,5
129,Serotonin and anxiety-related events WP3944,0.3802551258310669,3.7032640949554896,3.580733706174176,['CRH'],0.9834184288734489,0,0,1
130,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.3802551258310669,3.7032640949554896,3.580733706174176,['CDC37'],0.9834184288734489,0,0,1
131,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.3802551258310669,3.7032640949554896,3.580733706174176,['DLL3'],0.9834184288734489,0,0,1
132,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.3802551258310669,3.7032640949554896,3.580733706174176,['HMGCS1'],0.9834184288734489,0,0,1
133,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.3802551258310669,3.7032640949554896,3.580733706174176,['ACLY'],0.9834184288734489,0,0,1
134,TCA cycle in senescence WP5050,0.3802551258310669,3.7032640949554896,3.580733706174176,['GOT1'],0.9834184288734489,0,0,1
135,Cell Differentiation - Index WP2029,0.3802551258310669,3.7032640949554896,3.580733706174176,['MEF2D'],0.9834184288734489,0,0,1
136,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3802551258310669,3.7032640949554896,3.580733706174176,['CCK'],0.9834184288734489,0,0,1
137,FOXP3 in COVID-19 WP5063,0.3802551258310669,3.7032640949554896,3.580733706174176,['CD80'],0.9834184288734489,0,0,1
138,Glycerolipids and Glycerophospholipids WP4722,0.3802551258310669,3.7032640949554896,3.580733706174176,['CDIPT'],0.9834184288734489,0,0,1
139,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.3802551258310669,3.7032640949554896,3.580733706174176,['HRAS'],0.9834184288734489,0,0,1
140,Insulin signaling in adipocytes (diabetic condition) WP3635,0.3802551258310669,3.7032640949554896,3.580733706174176,['RPS6'],0.9834184288734489,0,0,1
141,Insulin signaling in adipocytes (normal condition) WP3634,0.3802551258310669,3.7032640949554896,3.580733706174176,['RPS6'],0.9834184288734489,0,0,1
142,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3802551258310669,3.7032640949554896,3.580733706174176,['AHCY'],0.9834184288734489,0,0,1
143,MTHFR deficiency WP4288,0.3802551258310669,3.7032640949554896,3.580733706174176,['CYCS'],0.9834184288734489,0,0,1
144,NOTCH1 regulation of endothelial cell calcification WP3413,0.3802551258310669,3.7032640949554896,3.580733706174176,['DLL3'],0.9834184288734489,0,0,1
145,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.3802551258310669,3.7032640949554896,3.580733706174176,['MAS1'],0.9834184288734489,0,0,1
146,Thermogenesis WP4321,0.3998915026316919,1.347041847041847,1.2346473856915128,"['RPS6', 'CPT1B', 'HRAS', 'ACTG1']",0.9992941436613156,0,0,4
147,Leptin signaling pathway WP2034,0.3998915026316919,1.347041847041847,1.2346473856915128,"['BAD', 'RPS6', 'BAX', 'HRAS']",0.9992941436613156,0,0,4
148,Aryl Hydrocarbon Receptor Pathway WP2873,0.42488999602168154,1.3888751238850348,1.1887729077045324,"['CDC37', 'AIP', 'BAX']",0.9992941436613156,0,0,3
149,CAMKK2  Pathway WP4874,0.42488999602168154,1.3888751238850348,1.1887729077045324,"['FIS1', 'MAP1LC3A', 'CALM2']",0.9992941436613156,0,0,3
150,Sleep regulation WP3591,0.452803262568545,1.2344576719576719,0.9780577851203758,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9992941436613156,0,0,4
151,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.45811782424586533,1.4811881188118812,1.1562582071114151,"['RPS6', 'PIM2']",0.9992941436613156,0,0,2
152,Vitamin D-sensitive calcium signaling in depression WP4698,0.45811782424586533,1.4811881188118812,1.1562582071114151,"['GPX4', 'PVALB']",0.9992941436613156,0,0,2
153,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.45811782424586533,1.4811881188118812,1.1562582071114151,"['CD63', 'SOD1']",0.9992941436613156,0,0,2
154,Interleukin-11 Signaling Pathway WP2332,0.45811782424586533,1.4811881188118812,1.1562582071114151,"['RPS6', 'HRAS']",0.9992941436613156,0,0,2
155,Macrophage markers WP4146,0.45811782424586533,1.4811881188118812,1.1562582071114151,"['CD163', 'CD14']",0.9992941436613156,0,0,2
156,PDGF Pathway WP2526,0.45811782424586533,1.4811881188118812,1.1562582071114151,"['ARFIP2', 'HRAS']",0.9992941436613156,0,0,2
157,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.45811782424586533,1.4811881188118812,1.1562582071114151,"['LDHA', 'CD80']",0.9992941436613156,0,0,2
158,Insulin Signaling WP481,0.4873377221481029,1.1108349900596421,0.798465882101219,"['XBP1', 'SHC3', 'HRAS', 'PFKM', 'VAMP2', 'ARF6']",0.9992941436613156,0,0,6
159,ACE Inhibitor Pathway WP554,0.512154357932668,1.851137487636004,1.2386501814402355,['MAS1'],0.9992941436613156,0,0,1
160,Airway smooth muscle cell contraction WP4962,0.512154357932668,1.851137487636004,1.2386501814402355,['CALM2'],0.9992941436613156,0,0,1
161,Splicing factor NOVA regulated synaptic proteins WP4148,0.512154357932668,1.851137487636004,1.2386501814402355,['APLP2'],0.9992941436613156,0,0,1
162,Cancer immunotherapy by CTLA4 blockade WP4582,0.512154357932668,1.851137487636004,1.2386501814402355,['CD80'],0.9992941436613156,0,0,1
163,Trans-sulfuration and one-carbon metabolism WP2525,0.512154357932668,1.851137487636004,1.2386501814402355,['AHCY'],0.9992941436613156,0,0,1
164,Dopamine metabolism WP2436,0.512154357932668,1.851137487636004,1.2386501814402355,['SOD1'],0.9992941436613156,0,0,1
165,Fatty Acid Biosynthesis WP357,0.512154357932668,1.851137487636004,1.2386501814402355,['ACLY'],0.9992941436613156,0,0,1
166,Hippo-Yap signaling pathway WP4537,0.512154357932668,1.851137487636004,1.2386501814402355,['YWHAQ'],0.9992941436613156,0,0,1
167,Iron metabolism in placenta WP2007,0.512154357932668,1.851137487636004,1.2386501814402355,['FTH1'],0.9992941436613156,0,0,1
168,LTF danger signal response pathway WP4478,0.512154357932668,1.851137487636004,1.2386501814402355,['CD14'],0.9992941436613156,0,0,1
169,Overview of nanoparticle effects WP3287,0.512154357932668,1.851137487636004,1.2386501814402355,['BAX'],0.9992941436613156,0,0,1
170,Phosphoinositides metabolism WP4971,0.512154357932668,1.851137487636004,1.2386501814402355,['PIP4P1'],0.9992941436613156,0,0,1
171,Purine metabolism and related disorders WP4224,0.512154357932668,1.851137487636004,1.2386501814402355,['APRT'],0.9992941436613156,0,0,1
172,Purine metabolism WP4792,0.512154357932668,1.851137487636004,1.2386501814402355,['APRT'],0.9992941436613156,0,0,1
173,Rett syndrome causing genes WP4312,0.512154357932668,1.851137487636004,1.2386501814402355,['IMPDH2'],0.9992941436613156,0,0,1
174,TNF-alpha signaling pathway WP231,0.5276027018589666,1.0576540755467196,0.6762764297124925,"['BAD', 'CDC37', 'BAX', 'TXN', 'HRAS', 'SKP1']",0.9992941436613156,0,0,6
175,Hepatitis B infection WP4666,0.5276027018589666,1.0576540755467196,0.6762764297124925,"['YWHAQ', 'YWHAB', 'BAD', 'CYCS', 'BAX', 'HRAS']",0.9992941436613156,0,0,6
176,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5276027018589666,1.0576540755467196,0.6762764297124925,"['PSMD8', 'PSMC5', 'PSMD7', 'PSMC3', 'UBE2L6', 'STUB1']",0.9992941436613156,0,0,6
177,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5336083097864303,1.233993399339934,0.7750628770858942,"['TNFRSF11B', 'PPIB']",0.9992941436613156,0,0,2
178,Endothelin Pathways WP2197,0.5336083097864303,1.233993399339934,0.7750628770858942,"['RIIAD1', 'CALM2']",0.9992941436613156,0,0,2
179,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5336083097864303,1.233993399339934,0.7750628770858942,"['BANF1', 'HRAS']",0.9992941436613156,0,0,2
180,G13 Signaling Pathway WP524,0.5336083097864303,1.233993399339934,0.7750628770858942,"['ARHGDIG', 'CALM2']",0.9992941436613156,0,0,2
181,Galanin receptor pathway WP4970,0.5336083097864303,1.233993399339934,0.7750628770858942,"['POMC', 'VAMP2']",0.9992941436613156,0,0,2
182,IL-2 signaling pathway WP49,0.5336083097864303,1.233993399339934,0.7750628770858942,"['RPS6', 'HRAS']",0.9992941436613156,0,0,2
183,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5446789998102417,1.1105054509415262,0.6746971914991619,"['LDHA', 'PGK1', 'BAX']",0.9992941436613156,0,0,3
184,Calcium Regulation in the Cardiac Cell WP536,0.551306312700405,1.0093356294752107,0.6010237407115987,"['RGS4', 'GNG3', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'CALM3', 'CALR', 'CALM2', 'YWHAH']",0.9992941436613156,0,0,9
185,Exercise-induced Circadian Regulation WP410,0.5531027105443258,1.0575396825396826,0.6262872265894702,"['IDI1', 'SUMO1', 'GSTP1', 'STBD1']",0.9992941436613156,0,0,4
186,Fragile X Syndrome  WP4549,0.5531027105443258,1.0575396825396826,0.6262872265894702,"['HOMER1', 'PRKAR1A', 'AP2S1', 'AP2M1']",0.9992941436613156,0,0,4
187,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5576733052188434,1.0001618384851918,0.5840764733323621,"['YWHAQ', 'PRKAR1A', 'YWHAB', 'TAC1', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9992941436613156,0,0,10
188,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.5665087459377887,1.009307789625881,0.5735520303077276,"['RAB3A', 'SHC3', 'CDK5', 'BAD', 'RPS6', 'HRAS']",0.9992941436613156,0,0,6
189,DNA damage response WP707,0.5994176133180058,0.9867724867724867,0.505026941473304,"['CDK5', 'GADD45A', 'CYCS', 'BAX']",0.9992941436613156,0,0,4
190,miRNA regulation of DNA damage response WP1530,0.5994176133180058,0.9867724867724867,0.505026941473304,"['CDK5', 'GADD45A', 'CYCS', 'BAX']",0.9992941436613156,0,0,4
191,Gastrin signaling pathway WP4659,0.6013094263955588,0.9737103433857732,0.4952735055634742,"['BAD', 'RPS6', 'KIT', 'HRAS', 'MEF2D']",0.9992941436613156,0,0,5
192,Urea cycle and associated pathways WP4595,0.6015345237270162,1.0574257425742575,0.5374592088143142,"['GOT1', 'MDH2']",0.9992941436613156,0,0,2
193,DNA Replication WP466,0.6015345237270162,1.0574257425742575,0.5374592088143142,"['POLE', 'UBA52']",0.9992941436613156,0,0,2
194,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6015345237270162,1.0574257425742575,0.5374592088143142,"['RAB3A', 'NEFL']",0.9992941436613156,0,0,2
195,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6015345237270162,1.0574257425742575,0.5374592088143142,"['YWHAQ', 'ACTG1']",0.9992941436613156,0,0,2
196,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6015345237270162,1.0574257425742575,0.5374592088143142,"['TKFC', 'PIN1']",0.9992941436613156,0,0,2
197,Oxidative Stress WP408,0.6015345237270162,1.0574257425742575,0.5374592088143142,"['TXN2', 'SOD1']",0.9992941436613156,0,0,2
198,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6160034881352151,1.233761951862842,0.5977609387338602,['HRAS'],0.9992941436613156,0,0,1
199,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.6160034881352151,1.233761951862842,0.5977609387338602,['MEF2D'],0.9992941436613156,0,0,1
200,Statin inhibition of cholesterol production WP430,0.6160034881352151,1.233761951862842,0.5977609387338602,['APOC1'],0.9992941436613156,0,0,1
201,Sulfation Biotransformation Reaction WP692,0.6160034881352151,1.233761951862842,0.5977609387338602,['SULT4A1'],0.9992941436613156,0,0,1
202,Biomarkers for urea cycle disorders WP4583,0.6160034881352151,1.233761951862842,0.5977609387338602,['GOT1'],0.9992941436613156,0,0,1
203,Cell Differentiation - Index expanded WP2023,0.6160034881352151,1.233761951862842,0.5977609387338602,['MEF2D'],0.9992941436613156,0,0,1
204,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6160034881352151,1.233761951862842,0.5977609387338602,['H3F3A'],0.9992941436613156,0,0,1
205,Gastric Cancer Network 1 WP2361,0.6160034881352151,1.233761951862842,0.5977609387338602,['H3F3A'],0.9992941436613156,0,0,1
206,Gastric Cancer Network 2 WP2363,0.6160034881352151,1.233761951862842,0.5977609387338602,['S100A6'],0.9992941436613156,0,0,1
207,Glycerophospholipid Biosynthetic Pathway WP2533,0.6160034881352151,1.233761951862842,0.5977609387338602,['CDIPT'],0.9992941436613156,0,0,1
208,Hedgehog Signaling Pathway WP4249,0.6160034881352151,1.233761951862842,0.5977609387338602,['SMO'],0.9992941436613156,0,0,1
209,Intraflagellar transport proteins binding to dynein WP4532,0.6160034881352151,1.233761951862842,0.5977609387338602,['DYNLL1'],0.9992941436613156,0,0,1
210,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6160034881352151,1.233761951862842,0.5977609387338602,['BAX'],0.9992941436613156,0,0,1
211,Nanoparticle triggered regulated necrosis WP2513,0.6160034881352151,1.233761951862842,0.5977609387338602,['FTL'],0.9992941436613156,0,0,1
212,One-carbon metabolism WP241,0.6160034881352151,1.233761951862842,0.5977609387338602,['AHCY'],0.9992941436613156,0,0,1
213,Osteoblast Signaling WP322,0.6160034881352151,1.233761951862842,0.5977609387338602,['TNFRSF11B'],0.9992941436613156,0,0,1
214,PDGFR-beta pathway WP3972,0.6160034881352151,1.233761951862842,0.5977609387338602,['HRAS'],0.9992941436613156,0,0,1
215,PPAR-alpha pathway WP2878,0.6160034881352151,1.233761951862842,0.5977609387338602,['DBI'],0.9992941436613156,0,0,1
216,AGE/RAGE pathway WP2324,0.6616959945141462,0.925,0.38197787246036674,"['CYCS', 'SOD1']",0.9992941436613156,0,0,2
217,Blood Clotting Cascade WP272,0.6616959945141462,0.925,0.38197787246036674,"['F8A1', 'F11']",0.9992941436613156,0,0,2
218,Cardiac Hypertrophic Response WP2795,0.6616959945141462,0.925,0.38197787246036674,"['NPPA', 'CALM2']",0.9992941436613156,0,0,2
219,Cardiac Progenitor Differentiation WP2406,0.6616959945141462,0.925,0.38197787246036674,"['MESP1', 'KIT']",0.9992941436613156,0,0,2
220,Unfolded protein response WP4925,0.6616959945141462,0.925,0.38197787246036674,"['XBP1', 'DDIT3']",0.9992941436613156,0,0,2
221,Common Pathways Underlying Drug Addiction WP2636,0.6616959945141462,0.925,0.38197787246036674,"['CALM2', 'ACTG1']",0.9992941436613156,0,0,2
222,DNA IR-double strand breaks and cellular response via ATM WP3959,0.6616959945141462,0.925,0.38197787246036674,"['CDK5', 'BAX']",0.9992941436613156,0,0,2
223,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6616959945141462,0.925,0.38197787246036674,"['H2AFZ', 'H3F3A']",0.9992941436613156,0,0,2
224,Integrated Cancer Pathway WP1971,0.6616959945141462,0.925,0.38197787246036674,"['BAD', 'BAX']",0.9992941436613156,0,0,2
225,TGF-beta Signaling Pathway WP366,0.6765072419927067,0.8805031446540881,0.34411130621096503,"['PARD6A', 'CITED1', 'SUMO1', 'STRAP', 'SKP1']",0.9992941436613156,0,0,5
226,Ciliopathies WP4803,0.6765072419927067,0.8805031446540881,0.34411130621096503,"['RPGRIP1', 'DNAAF3', 'SMO', 'NEK2', 'CCNQ']",0.9992941436613156,0,0,5
227,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6828150614412026,0.8702147525676938,0.33201410487248023,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9992941436613156,0,0,4
228,Ectoderm Differentiation WP2858,0.6828150614412026,0.8702147525676938,0.33201410487248023,"['MAFB', 'ARHGDIG', 'TNFRSF11B', 'LY6E']",0.9992941436613156,0,0,4
229,Pathogenic Escherichia coli infection WP2272,0.6828150614412026,0.8702147525676938,0.33201410487248023,"['YWHAQ', 'ARPC5L', 'CD14', 'ACTG1']",0.9992941436613156,0,0,4
230,Circadian rhythm related genes WP3594,0.6937130230077091,0.8836598184424271,0.3231516699654635,"['OPN4', 'AHCY', 'HOMER1', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1', 'NR2F6', 'HCRTR1']",0.9992941436613156,0,0,11
231,G1 to S cell cycle control WP45,0.6937360306484829,0.8535488297629031,0.31211186600711327,"['CDKN2D', 'GADD45A', 'POLE']",0.9992941436613156,0,0,3
232,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6977630832703842,0.9250741839762612,0.3329116788860003,['HRAS'],0.9992941436613156,0,0,1
233,Cannabinoid receptor signaling WP3869,0.6977630832703842,0.9250741839762612,0.3329116788860003,['PRKAR1A'],0.9992941436613156,0,0,1
234,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6977630832703842,0.9250741839762612,0.3329116788860003,['STAR'],0.9992941436613156,0,0,1
235,Disruption of postsynaptic signaling by CNV WP4875,0.6977630832703842,0.9250741839762612,0.3329116788860003,['HOMER1'],0.9992941436613156,0,0,1
236,ERK Pathway in Huntington's Disease WP3853,0.6977630832703842,0.9250741839762612,0.3329116788860003,['HRAS'],0.9992941436613156,0,0,1
237,Ethanol effects on histone modifications WP3996,0.6977630832703842,0.9250741839762612,0.3329116788860003,['AHCY'],0.9992941436613156,0,0,1
238,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6977630832703842,0.9250741839762612,0.3329116788860003,['HRAS'],0.9992941436613156,0,0,1
239,Genes targeted by miRNAs in adipocytes WP1992,0.6977630832703842,0.9250741839762612,0.3329116788860003,['TMSB4X'],0.9992941436613156,0,0,1
240,IL-7 signaling pathway WP205,0.6977630832703842,0.9250741839762612,0.3329116788860003,['BAD'],0.9992941436613156,0,0,1
241,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6977630832703842,0.9250741839762612,0.3329116788860003,['SUPT4H1'],0.9992941436613156,0,0,1
242,Nicotine Activity on Dopaminergic Neurons WP1602,0.6977630832703842,0.9250741839762612,0.3329116788860003,['CDK5'],0.9992941436613156,0,0,1
243,Physiological and pathological hypertrophy of the heart WP1528,0.6977630832703842,0.9250741839762612,0.3329116788860003,['CALM2'],0.9992941436613156,0,0,1
244,Proteoglycan biosynthesis WP4784,0.6977630832703842,0.9250741839762612,0.3329116788860003,['XYLT1'],0.9992941436613156,0,0,1
245,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6977630832703842,0.9250741839762612,0.3329116788860003,['BAX'],0.9992941436613156,0,0,1
246,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6977630832703842,0.9250741839762612,0.3329116788860003,['HRAS'],0.9992941436613156,0,0,1
247,SARS-CoV-2 mitochondrial interactions WP5038,0.6977630832703842,0.9250741839762612,0.3329116788860003,['PHB'],0.9992941436613156,0,0,1
248,Adipogenesis WP236,0.7042165371269108,0.8531120966508641,0.2991602976565813,"['GADD45A', 'DDIT3', 'HMGA1', 'NDN', 'MIF', 'MEF2D']",0.9992941436613156,0,0,6
249,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7143194918809107,0.822002200220022,0.2765420483740492,"['SHC3', 'HRAS']",0.9992941436613156,0,0,2
250,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7143194918809107,0.822002200220022,0.2765420483740492,"['CYCS', 'ACTG1']",0.9992941436613156,0,0,2
251,Glycogen Synthesis and Degradation WP500,0.7143194918809107,0.822002200220022,0.2765420483740492,"['CALM3', 'CALM2']",0.9992941436613156,0,0,2
252,p53 transcriptional gene network WP4963,0.7143194918809107,0.822002200220022,0.2765420483740492,"['GADD45A', 'BAX']",0.9992941436613156,0,0,2
253,Regulation of Microtubule Cytoskeleton WP2038,0.7143194918809107,0.822002200220022,0.2765420483740492,"['PARD6A', 'STMN1']",0.9992941436613156,0,0,2
254,Oxidative Damage WP3941,0.7343766514827121,0.792368681863231,0.2446305447406173,"['BAD', 'GADD45A', 'CYCS']",0.9992941436613156,0,0,3
255,Prolactin Signaling Pathway WP2037,0.7343766514827121,0.792368681863231,0.2446305447406173,"['RPS6', 'PPIB', 'HRAS']",0.9992941436613156,0,0,3
256,DNA damage response (only ATM dependent) WP710,0.7532033360585396,0.7781954887218046,0.22055620668025328,"['BAD', 'RAC3', 'BAX', 'HRAS']",0.9992941436613156,0,0,4
257,Head and Neck Squamous Cell Carcinoma WP4674,0.759886594028163,0.7396039603960396,0.2030849487022628,"['RPS6', 'HRAS']",0.9992941436613156,0,0,2
258,Focal Adhesion WP306,0.7607589280766865,0.7917495029821073,0.21649499788121385,"['SHC3', 'BAD', 'RAC3', 'HRAS', 'MYL12B', 'ACTG1']",0.9992941436613156,0,0,6
259,15q13.3 copy number variation syndrome WP4942,0.76212809687281,0.7398615232443125,0.2009764512423364,['TRPM1'],0.9992941436613156,0,0,1
260,7-oxo-C and 7beta-HC pathways WP5064,0.76212809687281,0.7398615232443125,0.2009764512423364,['THEM5'],0.9992941436613156,0,0,1
261,Biogenic Amine Synthesis WP550,0.76212809687281,0.7398615232443125,0.2009764512423364,['GAD2'],0.9992941436613156,0,0,1
262,Bladder cancer WP2828,0.76212809687281,0.7398615232443125,0.2009764512423364,['HRAS'],0.9992941436613156,0,0,1
263,Fluoropyrimidine Activity WP1601,0.76212809687281,0.7398615232443125,0.2009764512423364,['TDG'],0.9992941436613156,0,0,1
264,Genes related to primary cilium development (based on CRISPR) WP4536,0.76212809687281,0.7398615232443125,0.2009764512423364,['DYNLL1'],0.9992941436613156,0,0,1
265,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.76212809687281,0.7398615232443125,0.2009764512423364,['SMO'],0.9992941436613156,0,0,1
266,MAPK Cascade WP422,0.76212809687281,0.7398615232443125,0.2009764512423364,['HRAS'],0.9992941436613156,0,0,1
267,miRNA regulation of prostate cancer signaling pathways WP3981,0.76212809687281,0.7398615232443125,0.2009764512423364,['BAD'],0.9992941436613156,0,0,1
268,Notch Signaling WP268,0.76212809687281,0.7398615232443125,0.2009764512423364,['DLL3'],0.9992941436613156,0,0,1
269,Retinoblastoma gene in cancer WP2446,0.7706313916516827,0.7393458870168483,0.19263295618823456,"['H2AFZ', 'STMN1', 'POLE']",0.9992941436613156,0,0,3
270,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7990151859424556,0.6721872187218721,0.15082222714755425,"['NPPA', 'CALM2']",0.9992941436613156,0,0,2
271,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7990151859424556,0.6721872187218721,0.15082222714755425,"['IFI27L2', 'HRAS']",0.9992941436613156,0,0,2
272,Breast cancer pathway WP4262,0.7999886204484825,0.7602282704126426,0.16965084996720772,"['SHC3', 'GADD45A', 'KIT', 'BAX', 'HRAS', 'SKP1', 'DLL3']",0.9992941436613156,0,0,7
273,Chemokine signaling pathway WP3929,0.8109065235468222,0.7037037037037037,0.14749805009563668,"['GNG10', 'GNG3', 'SHC3', 'HRAS']",0.9992941436613156,0,0,4
274,Proximal tubule transport WP4917,0.8109065235468222,0.7037037037037037,0.14749805009563668,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9992941436613156,0,0,4
275,Alpha 6 Beta 4 signaling pathway WP244,0.8127963871381525,0.6163864160896801,0.12776127688811276,['HRAS'],0.9992941436613156,0,0,1
276,Apoptosis Modulation by HSP70 WP384,0.8127963871381525,0.6163864160896801,0.12776127688811276,['CYCS'],0.9992941436613156,0,0,1
277,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8127963871381525,0.6163864160896801,0.12776127688811276,['CALM2'],0.9992941436613156,0,0,1
278,Target Of Rapamycin (TOR) Signaling WP1471,0.8127963871381525,0.6163864160896801,0.12776127688811276,['IDI1'],0.9992941436613156,0,0,1
279,Canonical and non-canonical Notch signaling WP3845,0.8127963871381525,0.6163864160896801,0.12776127688811276,['DLL3'],0.9992941436613156,0,0,1
280,Transcriptional cascade regulating adipogenesis WP4211,0.8127963871381525,0.6163864160896801,0.12776127688811276,['DDIT3'],0.9992941436613156,0,0,1
281,Urea cycle and metabolism of amino groups WP497,0.8127963871381525,0.6163864160896801,0.12776127688811276,['ODC1'],0.9992941436613156,0,0,1
282,Development of ureteric collection system WP5053,0.8127963871381525,0.6163864160896801,0.12776127688811276,['SMO'],0.9992941436613156,0,0,1
283,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8127963871381525,0.6163864160896801,0.12776127688811276,['MAP1LC3A'],0.9992941436613156,0,0,1
284,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8127963871381525,0.6163864160896801,0.12776127688811276,['CD14'],0.9992941436613156,0,0,1
285,Glutathione metabolism WP100,0.8127963871381525,0.6163864160896801,0.12776127688811276,['GPX4'],0.9992941436613156,0,0,1
286,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8127963871381525,0.6163864160896801,0.12776127688811276,['DDIT3'],0.9992941436613156,0,0,1
287,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8127963871381525,0.6163864160896801,0.12776127688811276,['CD80'],0.9992941436613156,0,0,1
288,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8127963871381525,0.6163864160896801,0.12776127688811276,['BAX'],0.9992941436613156,0,0,1
289,Neovascularisation processes WP4331,0.8127963871381525,0.6163864160896801,0.12776127688811276,['KIT'],0.9992941436613156,0,0,1
290,Nuclear receptors WP170,0.8127963871381525,0.6163864160896801,0.12776127688811276,['NR2F6'],0.9992941436613156,0,0,1
291,Complement system WP2806,0.8205256849107414,0.7383084577114428,0.146044843986221,"['FKBP2', 'FCGR3A', 'RPS19', 'F11', 'CD59', 'TXN', 'CALR']",0.9992941436613156,0,0,7
292,Corticotropin-releasing hormone signaling pathway WP2355,0.8309723969500324,0.6520142249169242,0.12072610714408584,"['POMC', 'STAR', 'CRH']",0.9992941436613156,0,0,3
293,Folate Metabolism WP176,0.8309723969500324,0.6520142249169242,0.12072610714408584,"['AHCY', 'GPX4', 'SOD1']",0.9992941436613156,0,0,3
294,3q29 copy number variation syndrome WP4906,0.8323797758072352,0.616006600660066,0.11301656329644513,"['NCBP2', 'DYNLL1']",0.9992941436613156,0,0,2
295,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8323797758072352,0.616006600660066,0.11301656329644513,"['BEX3', 'RNF7']",0.9992941436613156,0,0,2
296,Globo Sphingolipid Metabolism WP1424,0.8526803099863888,0.5281899109792285,0.08417793503707953,['ST6GAL2'],0.9992941436613156,0,0,1
297,Interferon type I signaling pathways WP585,0.8526803099863888,0.5281899109792285,0.08417793503707953,['RPS6'],0.9992941436613156,0,0,1
298,Joubert Syndrome WP4656,0.8526803099863888,0.5281899109792285,0.08417793503707953,['ARL2'],0.9992941436613156,0,0,1
299,Monoamine Transport WP727,0.8526803099863888,0.5281899109792285,0.08417793503707953,['TNFRSF11B'],0.9992941436613156,0,0,1
300,Pathways affected in adenoid cystic carcinoma WP3651,0.8526803099863888,0.5281899109792285,0.08417793503707953,['HRAS'],0.9992941436613156,0,0,1
301,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8526803099863888,0.5281899109792285,0.08417793503707953,['BAX'],0.9992941436613156,0,0,1
302,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8526803099863888,0.5281899109792285,0.08417793503707953,['GSTP1'],0.9992941436613156,0,0,1
303,Prion disease pathway WP3995,0.8526803099863888,0.5281899109792285,0.08417793503707953,['HSP90B1'],0.9992941436613156,0,0,1
304,Hippo-Merlin Signaling Dysregulation WP4541,0.8556652357240481,0.615626032375289,0.09596135980212263,"['PRKAR1A', 'KIT', 'HRAS']",0.9992941436613156,0,0,3
305,22q11.2 copy number variation syndrome WP4657,0.8570806824718972,0.6421670117322291,0.09903706405376586,"['RANBP1', 'MRPL40', 'DGCR6L', 'RAN']",0.9992941436613156,0,0,4
306,Zinc homeostasis WP3529,0.8606594980977498,0.5684691546077685,0.08530239242489283,"['MT3', 'SLC39A3']",0.9992941436613156,0,0,2
307,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8606594980977498,0.5684691546077685,0.08530239242489283,"['HMGCS1', 'CALM2']",0.9992941436613156,0,0,2
308,Endochondral Ossification WP474,0.8606594980977498,0.5684691546077685,0.08530239242489283,"['HMGCS1', 'CALM2']",0.9992941436613156,0,0,2
309,Microglia Pathogen Phagocytosis Pathway WP3937,0.8606594980977498,0.5684691546077685,0.08530239242489283,"['NCF4', 'RAC3']",0.9992941436613156,0,0,2
310,Oncostatin M Signaling Pathway WP2374,0.8606594980977498,0.5684691546077685,0.08530239242489283,"['RPS6', 'HRAS']",0.9992941436613156,0,0,2
311,Prader-Willi and Angelman Syndrome WP3998,0.8606594980977498,0.5684691546077685,0.08530239242489283,"['POMC', 'NDN']",0.9992941436613156,0,0,2
312,Pre-implantation embryo WP3527,0.8606594980977498,0.5684691546077685,0.08530239242489283,"['DDIT3', 'HMGA1']",0.9992941436613156,0,0,2
313,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8606594980977498,0.5684691546077685,0.08530239242489283,"['YWHAQ', 'CD80']",0.9992941436613156,0,0,2
314,IL-5 signaling pathway WP127,0.8840734459503211,0.46204253214638974,0.056930633501599215,['RPS6'],0.9992941436613156,0,0,1
315,Melatonin metabolism and effects WP3298,0.8840734459503211,0.46204253214638974,0.056930633501599215,['CALM2'],0.9992941436613156,0,0,1
316,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8840734459503211,0.46204253214638974,0.056930633501599215,['YWHAQ'],0.9992941436613156,0,0,1
317,Oxysterols derived from cholesterol WP4545,0.8840734459503211,0.46204253214638974,0.056930633501599215,['THEM5'],0.9992941436613156,0,0,1
318,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8840734459503211,0.46204253214638974,0.056930633501599215,['BAX'],0.9992941436613156,0,0,1
319,Apoptosis WP254,0.8957336232955164,0.5537661050545094,0.060976407234764544,"['BAD', 'CYCS', 'BAX']",0.9992941436613156,0,0,3
320,B Cell Receptor Signaling Pathway WP23,0.9045227818985091,0.4924092409240924,0.04941217771363571,"['HRAS', 'MEF2D']",0.9992941436613156,0,0,2
321,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.908165874930747,0.5676129426129426,0.054677153165337944,"['STRAP', 'HRAS', 'MEF2D', 'DLL3']",0.9992941436613156,0,0,4
322,Striated Muscle Contraction Pathway WP383,0.908781965835859,0.41059457083195955,0.03927340155328475,['ACTG1'],0.9992941436613156,0,0,1
323,ATM Signaling Network in Development and Disease  WP3878,0.908781965835859,0.41059457083195955,0.03927340155328475,['CDK5'],0.9992941436613156,0,0,1
324,ATM Signaling Pathway WP2516,0.908781965835859,0.41059457083195955,0.03927340155328475,['GADD45A'],0.9992941436613156,0,0,1
325,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.908781965835859,0.41059457083195955,0.03927340155328475,['RPS6'],0.9992941436613156,0,0,1
326,Glioblastoma signaling pathways WP2261,0.908781965835859,0.41059457083195955,0.03927340155328475,['HRAS'],0.9992941436613156,0,0,1
327,Inflammatory Response Pathway WP453,0.908781965835859,0.41059457083195955,0.03927340155328475,['CD80'],0.9992941436613156,0,0,1
328,NRF2 pathway WP2884,0.911103703597059,0.6292440237835214,0.05858170828528824,"['SERPINA1', 'FTH1', 'PRDX1', 'GSTP1', 'TXN', 'SLC39A3', 'FTL']",0.9992941436613156,0,0,7
329,Endoderm differentiation WP2853,0.9212591443512608,0.46150990099009903,0.03785023125410733,"['TCEAL2', 'NME1']",0.9992941436613156,0,0,2
330,MECP2 and Associated Rett Syndrome WP3584,0.9212591443512608,0.46150990099009903,0.03785023125410733,"['RPS6', 'TET3']",0.9992941436613156,0,0,2
331,AMP-activated protein kinase (AMPK) signaling WP1403,0.9282281294257927,0.3694362017804154,0.027514776073889233,['CPT1B'],0.9992941436613156,0,0,1
332,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9282281294257927,0.3694362017804154,0.027514776073889233,['ACTG1'],0.9992941436613156,0,0,1
333,White fat cell differentiation WP4149,0.9282281294257927,0.3694362017804154,0.027514776073889233,['DDIT3'],0.9992941436613156,0,0,1
334,Pregnane X receptor pathway WP2876,0.9282281294257927,0.3694362017804154,0.027514776073889233,['PSMC5'],0.9992941436613156,0,0,1
335,Prostaglandin Synthesis and Regulation WP98,0.9282281294257927,0.3694362017804154,0.027514776073889233,['S100A6'],0.9992941436613156,0,0,1
336,RANKL/RANK signaling pathway WP2018,0.9282281294257927,0.3694362017804154,0.027514776073889233,['TNFRSF11B'],0.9992941436613156,0,0,1
337,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9286656106394046,0.6457260916762966,0.04778796058351973,"['GNG10', 'GNG3', 'RAB14', 'BAD', 'CDC37', 'KIT', 'RPS6', 'PELO', 'HRAS', 'HSP90B1']",0.9992941436613156,0,0,10
338,Vitamin D Receptor Pathway WP2877,0.9323361686560095,0.6137118193891102,0.04299777521426605,"['CDKN2D', 'LRRC25', 'COLEC11', 'GADD45A', 'PNOC', 'S100A6', 'TNFRSF11B', 'CD14']",0.9992941436613156,0,0,8
339,Pathways Regulating Hippo Signaling WP4540,0.9352032275033182,0.43424577751892834,0.029090740263295455,"['PRKAR1A', 'KIT']",0.9992941436613156,0,0,2
340,Apoptosis Modulation and Signaling WP1772,0.9399213722607265,0.5419417022022315,0.033578195054919956,"['ENDOG', 'BAD', 'CYCS', 'BAX', 'TNFRSF11B']",0.9992941436613156,0,0,5
341,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9435318240451961,0.3357611725564248,0.01951618025881883,['CALM2'],0.9992941436613156,0,0,1
342,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9435318240451961,0.3357611725564248,0.01951618025881883,['HRAS'],0.9992941436613156,0,0,1
343,TGF-beta Receptor Signaling WP560,0.9435318240451961,0.3357611725564248,0.01951618025881883,['HRAS'],0.9992941436613156,0,0,1
344,IL-4 signaling pathway WP395,0.9435318240451961,0.3357611725564248,0.01951618025881883,['BAD'],0.9992941436613156,0,0,1
345,Ovarian infertility WP34,0.9435318240451961,0.3357611725564248,0.01951618025881883,['FSHR'],0.9992941436613156,0,0,1
346,Differentiation Pathway WP2848,0.9555747986545601,0.3076986482030992,0.013982514635499946,['KIT'],0.9992941436613156,0,0,1
347,Toll-like Receptor Signaling Pathway WP75,0.9563758027925021,0.38832725377800936,0.017321082419324018,"['CD80', 'CD14']",0.9992941436613156,0,0,2
348,Osteoblast differentiation WP4787,0.9563758027925021,0.38832725377800936,0.017321082419324018,"['SMO', 'DLL3']",0.9992941436613156,0,0,2
349,Metapathway biotransformation Phase I and II WP702,0.9616629611134861,0.4975978958104082,0.019451719752375765,"['GPX4', 'GSTO1', 'GSTP1', 'KCNAB1', 'SULT4A1']",0.9992941436613156,0,0,5
350,T-cell receptor (TCR) signaling pathway WP69,0.9650512633089404,0.28395343528874684,0.01010137553731688,['HRAS'],0.9992941436613156,0,0,1
351,Vitamin A and carotenoid metabolism WP716,0.9650512633089404,0.28395343528874684,0.01010137553731688,['CRABP1'],0.9992941436613156,0,0,1
352,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9650512633089404,0.28395343528874684,0.01010137553731688,['STMN1'],0.9992941436613156,0,0,1
353,Peptide GPCRs WP24,0.9708290382760101,0.35115511551155115,0.010395909929948021,"['FSHR', 'HCRTR1']",0.9992941436613156,0,0,2
354,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9725077455045341,0.2636003956478734,0.007348451227905931,['TNFRSF11B'],0.9992941436613156,0,0,1
355,Male infertility WP4673,0.9725077455045341,0.2636003956478734,0.007348451227905931,['HMGA1'],0.9992941436613156,0,0,1
356,MAPK Signaling Pathway WP382,0.9742182715238912,0.49039098740888004,0.012808964715235634,"['GADD45A', 'DDIT3', 'STMN1', 'RAC3', 'CD14', 'HRAS']",0.9992941436613156,0,0,6
357,Neural Crest Differentiation WP2064,0.978374482811058,0.24596109462578306,0.005377392188036048,['DLL3'],0.9992941436613156,0,0,1
358,Mesodermal commitment pathway WP2857,0.9806072881227363,0.3204476969436074,0.006275396941199481,"['PRKAR1A', 'RPL38']",0.9992941436613156,0,0,2
359,PI3K-Akt signaling pathway WP4172,0.9817901704371438,0.5065256216513258,0.009308760308690024,"['GNG10', 'GNG3', 'BAD', 'CDC37', 'KIT', 'RPS6', 'HRAS', 'HSP90B1']",0.9992941436613156,0,0,8
360,Vitamin B12 metabolism WP1533,0.9829901478189353,0.230526706231454,0.003954958001145553,['SOD1'],0.9992941436613156,0,0,1
361,Lung fibrosis WP3624,0.9829901478189353,0.230526706231454,0.003954958001145553,['SERPINA1'],0.9992941436613156,0,0,1
362,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9829901478189353,0.230526706231454,0.003954958001145553,['NDUFA13'],0.9992941436613156,0,0,1
363,Regulation of toll-like receptor signaling pathway WP1449,0.9852265503590844,0.3562134339333099,0.005301761024309113,"['CUEDC2', 'CD80', 'CD14']",0.9992941436613156,0,0,3
364,Spinal Cord Injury WP2431,0.9893113854318448,0.40825333774688294,0.00438715084836414,"['GADD45A', 'APEX1', 'XYLT1', 'MIF', 'AIF1']",0.9992941436613156,0,0,5
365,ESC Pluripotency Pathways WP3931,0.9894778202611108,0.20480272557423893,0.0021663887491448447,['HRAS'],0.9992941436613156,0,0,1
366,Ebola Virus Pathway on Host WP4217,0.989585747789715,0.28324447829398325,0.002965246788624852,"['CLEC4G', 'ACTG1']",0.9992941436613156,0,0,2
367,"GPCRs, Other WP117",0.989585747789715,0.28324447829398325,0.002965246788624852,"['SMO', 'FSHR']",0.9992941436613156,0,0,2
368,Wnt signaling pathway and pluripotency WP399,0.9948822763324533,0.1754038905374217,0.0008999735191898219,['PPM1J'],0.9992941436613156,0,0,1
369,Allograft Rejection WP2328,0.9959755548058777,0.16738602643647155,0.0006749950427986388,['CD80'],0.9992941436613156,0,0,1
370,Nuclear Receptors Meta-Pathway WP2882,0.9959860067178766,0.48733333333333334,0.001960089255772439,"['PSMC5', 'SERPINA1', 'FTH1', 'CDC37', 'PRDX1', 'GSTP1', 'AIP', 'BAX', 'DBI', 'TXN', 'SLC39A3', 'FTL']",0.9992941436613156,0,0,12
371,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9968353420629462,0.16006536790951706,0.0005073553641966107,['SFRP2'],0.9992941436613156,0,0,1
372,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9975114644116767,0.15335476425980876,0.00038210442616835367,['SFRP2'],0.9992941436613156,0,0,1
373,Wnt signaling WP428,0.9980431237932413,0.14718100890207717,0.00028829718745021997,['SFRP2'],0.9992941436613156,0,0,1
374,Complement and Coagulation Cascades WP558,0.9984611611571913,0.14148215780263257,0.00021788592868598742,['SERPINA1'],0.9992941436613156,0,0,1
375,"GPCRs, Class A Rhodopsin-like WP455",0.9992941436613156,0.3274086822349485,0.00023118509503026379,"['MAS1', 'OPN4', 'FSHR', 'GPR65', 'GPR22', 'HCRTR1']",0.9992941436613156,0,0,6
